Table 1.
Clinical characteristics of the AML cohort in the TCGA data set with respect to CD97 expression
| Total | CD97 low (Z <1) | CD97 high (Z ≥1) |
p Value |
||
|---|---|---|---|---|---|
| T test | Fisher exact test | ||||
| Sex, No. (%) | 1 | ||||
| Female | 81 (46.8) | 69 (85.2) | 12 (14.8) | ||
| Male | 92 (53.1) | 78 (84.8) | 14 (15.2) | ||
| Age, y (range) | 0.385 | ||||
| Median | 58 | 57 | 62.5 | ||
| Mean | 55.2 ± 1.22 | 54.7 ± 1.32 | 57.7 ± 3.38 | ||
| WBC count x109/L | 0.004 | ||||
| Median | 17 | 13.1 | 56.1 | ||
| Mean | 36.63 ± 3.50 | 32.44 ± 3.81 | 60.30 ± 7.48 | ||
| PB blasts, % | 0.25 | ||||
| Median | 39 | 34.5 | 49 | ||
| Mean | 39.59 ± 2.44 | 38.38 ± 2.68 | 46.2 ± 5.85 | ||
| BM blasts, % | 0.019 | ||||
| Median | 72 | 71 | 83 | ||
| Mean | 69.08 ± 1.45 | 67.65 ± 1.59 | 77.15 ± 3.17 | ||
| NCCN subtype, No. | vs. favorable | ||||
| Favorable | 33 | 29 | 4 | ||
| Intermediate | 92 | 76 | 16 | 0.5 | |
| Poor | 45 | 40 | 5 | 0.6 | |
| FAB subtype, No. | vs. M5 | ||||
| M0 | 16 | 15 | 1 | 0.042 | |
| M1 | 44 | 39 | 5 | 0.028 | |
| M2 | 38 | 34 | 4 | 0.026 | |
| M3 | 16 | 12 | 4 | 0.476 | |
| M4 | 34 | 29 | 5 | 0.081 | |
| M5 | 18 | 11 | 7 | ||
| M6 | 2 | 2 | |||
| M7 | 3 | 3 | |||